1-3 of 3
Mikhail Doubrovin
Close
Sort by
Journal Articles

Targeted Therapy of B Cell Lymphoma with a Direct Inhibitor of the NF-κB Subunit c-Rel

Yusuke Shono, MD PhD, Andrea Z. Tuckett, PhD, Hsiou-Chi Liou, PhD, Samedy Ouk, PhD, Ekaterina Doubrovina, MD PhD, Mikhail Doubrovin, MD PhD, Enrico Derenzini, MD, Mary I. Scallion, BS, Jennifer J. Tsai, MD, Odette M. Smith, Anas Younes, MD PhD, Richard J. O'Reilly, MD PhD, Marcel R.M. van den Brink, MD PhD, Johannes L. Zakrzewski, MD
Journal: Blood
Blood (2014) 124 (21): 507.
https://doi.org/10.1182/blood.V124.21.507.507
Published: 2014
Journal Articles

Successful treatment of EBV-associated posttransplantation lymphoma after cord blood transplantation using third-party EBV-specific cytotoxic T lymphocytes

Brief Report
Juliet N. Barker, Ekaterina Doubrovina, Craig Sauter, Jennifer J. Jaroscak, Miguel A. Perales, Mikhail Doubrovin, Susan E. Prockop, Guenther Koehne, Richard J. O'Reilly
Journal: Blood
Blood (2010) 116 (23): 5045–5049.
https://doi.org/10.1182/blood-2010-04-281873
Published: 2010
Journal Articles

In Vivo Eradication of Human Clonigenic Acute Lymphoblastic Leukemic Cells Expressing the Wilms Tumor Protein, WT-1, by HLA Restricted WT-1 Specific T-Cells in NOD/SCID Mice Monitored by Bioluminescent Imaging.

Ekaterina Doubrovina, MD, PhD, Mikhail Doubrovin, MD, PhD, Elena Kanaeva, Richard J. O’Reilly, MD
Journal: Blood
Blood (2007) 110 (11): 581.
https://doi.org/10.1182/blood.V110.11.581.581
Published: 2007